Armata Pharmaceuticals, Inc. (ARMP) Misses Q3 EPS by 24c

Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q3 EPS of ($0.74), $0.24 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $0 versus the consensus estimate of $1.38 million.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.

You May Also Be Interested In

• Electra Therapeutics files for proposed IPO
• Blue Owl leads $2.4 billion debt deal for Iren data center
• IP Strategy Holdings receives Nasdaq noncompliance notice over late 10-Q